Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy: A Development and Validation Study

NCT04498611 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04498611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04498611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy: A Development and Validation Study
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 13, 2020
Completion date
August 15, 2021
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, ductal, breast, image, invasive breast cancer